Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Jones

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Nature Medicine|June 7, 2005
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg virusesSteven M Jones, Heinz Feldmann, Ute Ströher, et al.
Nature|January 19, 2007
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virusDarwyn Kobasa, Steven M Jones, Kyoko Shinya, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Discovery and Characterization of a Water-Soluble Prodrug of a Dual Inhibitor of Bacterial DNA Gyrase and Topoisomerase IVHardwin O'Dowd, Dean E Shannon, Kishan R Chandupatla, et al.
Antimicrobial Agents and Chemotherapy|December 31, 2014
Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunitRandal A Byrn, Steven M Jones, Hamilton B Bennett, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Carbohydrate consumption drives adaptive mutations in <i>Escherichia coli</i> associated with increased risk for systemic infectionAaron L Hecht, Nadim Mahmud, Subhan Chaudhry, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of InfluenzaUpul K Bandarage, Michael P Clark, Emanuele Perola, et al.
Nature Communications|February 9, 2026
Rapid dissemination of Staphylococcus aureus in the neonatal intensive care unit is associated with invasive infectionQianxuan She, Lakshmi Srinivasan, Erin Theiller, et al.
Journal of the Pediatric Infectious Diseases Society|September 4, 2025
Effect of maternal HIV status on the early neonatal microbiomeM Carolyn, Jonathan Strysko, One Bayani, et al.
PLOS Global Public Health|June 15, 2026
Integrated epidemiologic investigation and genomic confirmation of a Klebsiella pneumoniae neonatal sepsis outbreak in BotswanaJonathan Strysko, Weiming Hu, Kagiso Mochankana, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Discovery of Novel, Orally Bioavailable β-Amino Acid Azaindole Inhibitors of Influenza PB2Luc J Farmer, Michael P Clark, Michael J Boyd, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Nature Medicine|June 7, 2005
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg virusesSteven M Jones, Heinz Feldmann, Ute Ströher, et al.
Nature|January 19, 2007
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virusDarwyn Kobasa, Steven M Jones, Kyoko Shinya, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Discovery and Characterization of a Water-Soluble Prodrug of a Dual Inhibitor of Bacterial DNA Gyrase and Topoisomerase IVHardwin O'Dowd, Dean E Shannon, Kishan R Chandupatla, et al.
Antimicrobial Agents and Chemotherapy|December 31, 2014
Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunitRandal A Byrn, Steven M Jones, Hamilton B Bennett, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Carbohydrate consumption drives adaptive mutations in <i>Escherichia coli</i> associated with increased risk for systemic infectionAaron L Hecht, Nadim Mahmud, Subhan Chaudhry, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of InfluenzaUpul K Bandarage, Michael P Clark, Emanuele Perola, et al.
Nature Communications|February 9, 2026
Rapid dissemination of Staphylococcus aureus in the neonatal intensive care unit is associated with invasive infectionQianxuan She, Lakshmi Srinivasan, Erin Theiller, et al.
Journal of the Pediatric Infectious Diseases Society|September 4, 2025
Effect of maternal HIV status on the early neonatal microbiomeM Carolyn, Jonathan Strysko, One Bayani, et al.
PLOS Global Public Health|June 15, 2026
Integrated epidemiologic investigation and genomic confirmation of a Klebsiella pneumoniae neonatal sepsis outbreak in BotswanaJonathan Strysko, Weiming Hu, Kagiso Mochankana, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Discovery of Novel, Orally Bioavailable β-Amino Acid Azaindole Inhibitors of Influenza PB2Luc J Farmer, Michael P Clark, Michael J Boyd, et al.
Pageof 8